Literature DB >> 11874314

Physician-industry relations. Part 1: individual physicians.

Susan L Coyle1.   

Abstract

This is part 1 of a 2-part paper on ethics and physician-industry relationships. Part 1 offers advice to individual physicians; part 2 gives recommendations to medical education providers and medical professional societies. Physicians and industry have a shared interest in advancing medical knowledge. Nonetheless, the primary ethic of the physician is to promote the patient's best interests, while the primary ethic of industry is to promote profitability. Although partnerships between physicians and industry can result in impressive medical advances, they also create opportunities for bias and can result in unfavorable public perceptions. Many physicians and physicians-in-training think they are impervious to commercial influence. However, recent studies show that accepting industry hospitality and gifts, even drug samples, can compromise judgment about medical information and subsequent decisions about patient care. It is up to the physician to judge whether a gift is acceptable. A very general guideline is that it is ethical to accept modest gifts that advance medical practice. It is clearly unethical to accept gifts or services that obligate the physician to reciprocate. Conflicts of interest can arise from other financial ties between physicians and industry, whether to outside companies or self-owned businesses. Such ties include honorariums for speaking or writing about a company's product, payment for participating in clinic-based research, and referrals to medical resources. All of these relationships have the potential to influence a physician's attitudes and practices. This paper explores the ethical quandaries involved and offers guidelines for ethical business relationships.

Entities:  

Keywords:  American College of Physicians; American Society of Internal Medicine

Mesh:

Year:  2002        PMID: 11874314     DOI: 10.7326/0003-4819-136-5-200203050-00014

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  31 in total

1.  [Psychiatrists and the pharmaceutical industry].

Authors:  H Helmchen
Journal:  Nervenarzt       Date:  2003-11       Impact factor: 1.214

2.  How to dance with porcupines: rules and guidelines on doctors' relations with drug companies.

Authors:  Elizabeth Wager
Journal:  BMJ       Date:  2003-05-31

3.  The relationship between physicians and the pharmaceutical industry: ethical problems with the every-day conflict of interest.

Authors:  Richard L Allman
Journal:  HEC Forum       Date:  2003-06

4.  CME and the pharmaceutical industry: two worlds, three views, four steps.

Authors:  David A Davis
Journal:  CMAJ       Date:  2004-07-20       Impact factor: 8.262

5.  Physician remuneration in industry-sponsored clinical trials: the case for standardized clinical trial budgets.

Authors:  Lorraine E Ferris; C David Naylor
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

6.  Orthopaedic surgeons and industry: the value proposition.

Authors:  John J Callaghan; Steve S Liu
Journal:  Iowa Orthop J       Date:  2010

7.  Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures.

Authors:  Bimal H Ashar; Redonda G Miller; Kelly J Getz; Neil R Powe
Journal:  J Gen Intern Med       Date:  2004-11       Impact factor: 5.128

8.  Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.

Authors:  James L Wofford; Christopher A Ohl
Journal:  BMC Med Educ       Date:  2005-02-08       Impact factor: 2.463

9.  Bias in research and conflict of interest: why should we care?

Authors:  H P Dietz
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-11-21

10.  Interactions of doctors with the pharmaceutical industry.

Authors:  M A Morgan; J Dana; G Loewenstein; S Zinberg; J Schulkin
Journal:  J Med Ethics       Date:  2006-10       Impact factor: 2.903

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.